China’s National Development and Reform Commission (“NDRC”), one of the major regulatory authorities in charge of foreign investments in the People’s Republic of China (the “PRC” or “China”), recently denied the “national treatment” of RMB funds in the form of a limited liability partnership with a foreign-invested company as general partner (“GP”) and with only PRC domestic investors as limited partners (“LPs”).
View full memo, "China NDRC Denies the “National Treatment” for RMB Funds with Foreign GPs"
